NASDAQ:PSTV

Plus Therapeutics Stock Predictions

etoro logo Buy PSTV
*Your capital is at risk
$5.42
-0.0500 (-0.91%)
At Close: Jun 03, 2026
Currently predicting for Thu, 4 Jun 2026

PSTV Prediction Chart

PSTV Predictions History

Latest community submissions for PSTV.
Predictor Target Session Target Price Result Direction Accuracy Score
Sep 26, 2025 $0.548 -96.11% $0.617 V 88.74% 0
Sep 26, 2025 $0.410 -95.94% $0.617 X 66.44% 1
Sep 3, 2025 $0.458 -95.71% $0.460 X 99.59% 5
Sep 3, 2025 $0.447 -95.82% $0.460 X 97.09% 1
Sep 3, 2025 Bullish $0.460 X 1
Aug 19, 2025 $0.581 -95.67% $0.523 X 88.99% 0
Aug 19, 2025 $0.564 -95.79% $0.523 X 92.18% 0
Aug 19, 2025 Bullish $0.523 X 0
ir1998ri ir1998ri Amateur
Aug 18, 2025 Bearish $0.536 V 1
ir1998ri ir1998ri Amateur
Aug 14, 2025 Bearish $0.542 V 1
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for PSTV with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT PLUS THERAPEUTICS, INC.
Plus Therapeutics
Plus Therapeutics, Inc., a clinical-stage pharmaceutical company, focuses on the development, manufacture, and commercialization of treatments for patients with cancer and other diseases. Its lead drug candidate is Rhenium-186 NanoLiposome, a patented radiotherapy that targets central nervous system cancers, including recurrent glioblastoma, leptomeningeal metastases, and pediatric brain cancers. It has a license agreement with NanoTx, Corp. to d...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE